Viewing Study NCT00363051


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2026-01-02 @ 5:28 AM
Study NCT ID: NCT00363051
Status: COMPLETED
Last Update Posted: 2013-05-10
First Post: 2006-08-02
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy
Sponsor: Novartis Pharmaceuticals
Organization: